1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394–424.
2. Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018). Ovarian cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 284–296.
3. Zhang, M. L., Peng, P., Wu, C. X., Gong, Y. M., Zhang, S. W., Chen, W. Q., & Bao, P. P. (2019). Report of breast cancer incidence and mortality in China registry regions, 2008–2012. Zhonghua Zhong Liu Za Zhi, 41, 315–320.
4. Marth, C., Reimer, D., & Zeimet, A. G. (2017). Front-line therapy of advanced epithelial ovarian cancer: standard treatment. Ann Oncol, 28(Suppl 8), viii36–viii39.
5. Qiu, M. T., Hu, J. W., Yin, R., & Xu, L. (2013). Long noncoding RNA: An emerging paradigm of cancer research. Tumour Biology, 34, 613–620.